Abstract:
본 발명은 흰색 감국 추출물을 유효성분으로 포함하는 허혈성 뇌혈관 질환 예방 또는 개선용 조성물에 관한 것으로, 보다 상세하게는 뇌허혈에 민감하다고 알려져 있는 뇌 해마조직 CA1 영역의 신경 손상을 효과적으로 예방할 뿐만 아니라, 인체에 무해한 흰색 감국 추출물을 유효성분으로 포함하는 허혈성 뇌혈관 질환 예방 또는 개선용 조성물에 관한 것이다. 흰색 감국, 허혈성 뇌혈관 질환, 치매, 알츠하이머
Abstract:
A composition for preventing or treating brain ischemia diseases, which contains white Chrysanthemum indicum Var. albescens as an active ingredient is provided to prevent nerve injury of CA1 area of brain hippocampus. A composition for preventing and treating brain ischemia diseases comprises 0.001-99.99 weight% of Chrysanthemum indicum var. albescens extract as an active ingredient. The brain ischemia diseases are cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage and white matter. The Chrysanthemum indicum var. albescens extract is isolated with 30-80% of alcohol solution of 1-5 carbon atoms. The composition further comprises a carrier, excipient, and diluents. The composition is used in a form of powder, granule, tablet, suspension, emulsion or syrup.
Abstract:
PURPOSE: A pharmaceutical composition containing escitalopram is provided to prevent neural cell damage in a CA1 area and to prevent or treat ischemic brain diseases. CONSTITUTION: A pharmaceutical composition for preventing or treating ischemic a brain disease contains escitalopram. Ischemic brain disease is thrombosis, embolism, transient ischemic attack, cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage, white matter dyslipidemia, or lacune. The administering of escitalopram prevents or treats ischemic brain diseases. A pharmaceutical composition for preventing or treating brain disease contains escitalopram and a pharmaceologically acceptable carrier or excipient. The pharmaceutically acceptable carrier or excipient is water, dextrin, or a saline solution. The composition is used in the form of plasters, granules, lotions, powders, syrups, liquids and solutions, aerosols, ointments, fluid extract, emulsion, suspensions, infusions, tablets, injections, capsules, or pills.
Abstract:
A mask pack is provided to inhibit the damage induced by UVB by increasing anti-oxidase such as manganese superoxide dismutase and glutathione peroxidase without causing any skin irritation. A mask pack for improving skin damage caused by UVB comprises 0.1-0.4 parts by weight of coenzyme Q10, 7.0-12.0 parts by weight of glycerin, 0.05-0.3 parts by weight of allantoin, 85-95 parts by weight of purified water, 0.04-0.08 parts by weight of carbomer, and 0.05-0.3 parts by weight of triethanolamine. The pack is a sheet type or a patch type.
Abstract:
PURPOSE: An external use composition containing an Acorus calamus extract for preventing and treating atopic dermatitis is provided to suppress degranulation and excessive cytokine secretion. CONSTITUTION: A cosmetic composition for preventing or treating atopic dermatitis contains an Acorus calamus extract as an active ingredient. The extract is a solvent extract or essential oil. The solvent extract is prepared using water or butylenes glycol. A pharmaceutical composition for preventing or treating atopic dermatitis contains the extract as an active ingredient. An external use composition for preventing or treating atopic dermatitis contains the extract as an active ingredient. The external use composition is a cosmetic product or a medicine.
Abstract:
본 발명은 손바닥 선인장 ( Opuntia ficus indica ), 오리나무 ( Alnus japonica STEUD.), 갈근 ( Pueraria lobata (WILLD.), OHWI) 및 헛개나무 ( Hovenia dulcis THUNB.)로 구성된 복합생약추출물을 함유하는 숙취해소 및 간장 보호를 위한 기능성 식품 조성물에 관한 것으로서, 본 발명의 조성물은 인체에 부작용이 없으면서 알코올의 분해 작용 및 간장 보호 효과가 탁월하므로, 이를 유효성분으로 함유하는 조성물은 숙취해소 및 간장 보호를 위한 건강기능식품으로 유용하게 이용될 수 있다. 숙취해소, 복합 생약 추출물, 건강기능식품
Abstract:
본 발명은 창포 오일을 포함하는 여드름 피부 개선용 화장료 조성물에 관한 것으로서, 본 발명의 수증기 증류법으로 추출한 창포 오일은 여드름균 ( Propionibacterium acnes )에 대한 강한 항진균 작용을 나타내므로 여드름에 의한 피부트러블의 개선 효과가 탁월할 뿐만 아니라, 피부 자극이 전혀 없으므로 여드름 피부 개선을 위한 기능성 화장료 조성물로 이용될 수 있다.